Literature DB >> 34014496

Implications of a background of Hashimoto's thyroiditis on the current conservative surgical trend towards papillary thyroid carcinoma.

Shadi Hamouri1, Sohail Bakkar2, Almoutuz Aljaafreh1, Mohammed Bani Hani1, Hussein Heis1, Ghazi Qasaimeh1, Nasr Alrabadi3, Wisam Al Gargaz4, Haitham Odat4, Yazan Alkurdi1, Tarek Manasreh1, Mohammad Matalka1, Moamin Badwan1.   

Abstract

The purpose is to delineate the clinico-pathologic features of papillary thyroid carcinoma (PTC) occurring in a background of Hashimoto's thyroiditis (HT). A retrospective analysis of consecutive PTC patients who underwent surgery at an academic center between Jan. 2010 and Jan. 2020 was performed. The primary end point was to assess whether a background of HT implied a higher likelihood for postoperatively determined high-risk histopathologic features. Accordingly, its implication on initial surgical planning. Tumor high-risk features included aggressive histologic variants, lymphovascular invasion, extrathyroidal extension, multifocality, and positive nodal metastasis. To achieve the primary outcome of interest, a two group-designation was followed: group A (none-HT-group) and group B (HT-group). The two groups were also compared regarding postoperative complications as a secondary outcome of interest. In the specified period, 331 patients were found to have a histologically proven diagnosis of PTC. Group A accounted for 80% (265/331) of the study cohort, while group B accounted for the remainder 20%. PTC was significantly more prevalent in the absence of HT (p < 0.0001). Both groups were comparable in mean-patient-age. However, Group B demonstrated a considerably higher male:female ratio (1:10 vs. 1:3; p = 0.01). All postoperatively determined high-risk histopathologic features were comparable in both groups (p > 0.05). Nevertheless, transient hypoparathyroidism was considerably higher in group B (12% vs. 23%; p = 0.02). A background of HT does not seem to reflect a more aggressive cancerous biologic behavior. Therefore, it should not preclude the conservative surgical strategy adopted by the most recent clinical practice guidelines.

Entities:  

Keywords:  Extent of thyroid surgery; Hashimoto’s thyroiditis; Papillary thyroid carcinoma

Year:  2021        PMID: 34014496     DOI: 10.1007/s13304-021-01087-3

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  9 in total

Review 1.  Surgical management of papillary thyroid carcinoma: an overview.

Authors:  Paolo Miccoli; Sohail Bakkar
Journal:  Updates Surg       Date:  2017-04-12

2.  Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma: the influence of lymph node metastasis.

Authors:  Sang Soo Kim; Byung Joo Lee; Jin Choon Lee; Seong-Jang Kim; Yun Kyung Jeon; Mi Ra Kim; Jeong Eun Huh; Ji Young Mok; Bo Hyun Kim; Yong Ki Kim; In Joo Kim
Journal:  Head Neck       Date:  2010-11-29       Impact factor: 3.147

3.  Diabetes. 1.

Authors:  A R Holder
Journal:  JAMA       Date:  1973-01-22       Impact factor: 56.272

Review 4.  Energy-based devices in thyroid surgery-an overview.

Authors:  Sohail Bakkar; Theodosios S Papavramidis; Qusai Aljarrah; Gabriele Materazzi; Paolo Miccoli
Journal:  Gland Surg       Date:  2020-01

Review 5.  Thyroid nodules and cancer management guidelines: comparisons and controversies.

Authors:  Fadi Nabhan; Matthew D Ringel
Journal:  Endocr Relat Cancer       Date:  2016-12-13       Impact factor: 5.678

6.  BRAFV600E mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland.

Authors:  Sohail Bakkar; Elisabetta Macerola; Qusai Aljarrah; Agnese Proietti; Gabriele Materazzi; Fulvio Basolo; Paolo Miccoli
Journal:  Updates Surg       Date:  2019-10-04

7.  Thyroid cancer mortality and incidence: a global overview.

Authors:  Carlo La Vecchia; Matteo Malvezzi; Cristina Bosetti; Werner Garavello; Paola Bertuccio; Fabio Levi; Eva Negri
Journal:  Int J Cancer       Date:  2014-10-13       Impact factor: 7.396

8.  Impact of COVID-19 on thyroid cancer surgery and adjunct therapy.

Authors:  Sohail Bakkar; Khaled Al-Omar; Qusai Aljarrah; Moh'd Al-Dabbas; Nesrin Al-Dabbas; Samara Samara; Paolo Miccoli
Journal:  Updates Surg       Date:  2020-06-14

9.  Hashimoto's thyroiditis - an independent risk factor for papillary carcinoma.

Authors:  Barbora Uhliarova; Andrej Hajtman
Journal:  Braz J Otorhinolaryngol       Date:  2017-09-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.